JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Scope & Guideline

Pioneering the future of oncology with impactful research.

Introduction

Welcome to the JAPANESE JOURNAL OF CLINICAL ONCOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JAPANESE JOURNAL OF CLINICAL ONCOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0368-2811
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1971 to 2024
AbbreviationJPN J CLIN ONCOL / Jpn. J. Clin. Oncol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The Japanese Journal of Clinical Oncology focuses on advancing the understanding and treatment of cancer through high-quality research and clinical studies. It aims to provide a platform for innovative approaches in oncology, with a strong emphasis on both clinical and translational research.
  1. Clinical Trials and Therapeutics:
    The journal extensively publishes findings from clinical trials, including phase I-III studies, which evaluate new therapeutic approaches and combinations in various cancer types.
  2. Genomic Profiling and Precision Medicine:
    A significant emphasis is placed on genomic profiling and its implications for personalized cancer treatment, highlighting studies that explore molecular characteristics and targeted therapies.
  3. Multidisciplinary Approaches in Oncology:
    The journal promotes the integration of various specialties in cancer treatment, including surgery, radiotherapy, and supportive care, reflecting the complexity of cancer management.
  4. Health Economics and Policy in Cancer Care:
    Research addressing the cost-effectiveness of cancer treatments and the impact of health policies on cancer care in Japan is a core focus, aiming to improve healthcare delivery.
  5. Survivorship and Quality of Life:
    Studies that explore cancer survivorship, quality of life, and supportive care strategies for cancer patients, particularly in the context of the aging population in Japan, are frequently featured.
  6. Emerging Therapies and Technologies:
    The journal highlights innovative therapies, including immunotherapy and novel drug delivery systems, and their clinical implications, showcasing the evolving landscape of cancer treatment.
The Japanese Journal of Clinical Oncology has been adapting to the rapidly evolving landscape of cancer research. This section identifies the emerging trends and themes that have gained traction in recent publications, signaling areas of increased interest and research activity.
  1. Immunotherapy and Checkpoint Inhibitors:
    There is a growing emphasis on studies exploring the efficacy and safety of immunotherapy, particularly immune checkpoint inhibitors, as they have revolutionized cancer treatment.
  2. Real-world Evidence and Outcomes:
    The journal is increasingly publishing studies that focus on real-world evidence, assessing the effectiveness and safety of cancer treatments in everyday clinical settings, which is crucial for understanding treatment impacts beyond clinical trials.
  3. Multi-Omics Approaches:
    Research utilizing multi-omics technologies, integrating genomics, proteomics, and metabolomics, is on the rise, reflecting a trend towards comprehensive patient profiling to inform treatment decisions.
  4. Health Inequities and Access to Care:
    Emerging themes include the exploration of health disparities in cancer care, addressing how socioeconomic factors affect access to treatment and outcomes, particularly in the context of Japan's diverse population.
  5. Patient-Reported Outcomes and Quality of Life:
    There is a notable increase in studies focusing on patient-reported outcomes and quality of life assessments, highlighting the importance of patient perspectives in oncology research.

Declining or Waning

While the Japanese Journal of Clinical Oncology continues to thrive in many areas, certain themes have seen a decline in recent years. This section explores those waning scopes, indicating shifts in research focus or decreasing publication frequency.
  1. Traditional Chemotherapy Studies:
    With the advent of targeted therapies and immunotherapy, the focus on traditional chemotherapy regimens has diminished, reflecting a broader shift towards more innovative treatment modalities.
  2. Single-Institution Studies:
    There has been a noticeable decrease in the publication of studies from single institutions, as the journal increasingly prioritizes multicenter and population-based studies that provide more comprehensive data.
  3. Basic Science Research:
    The journal has seen a reduced emphasis on basic science research related to oncology, as it shifts towards clinical application and translational studies that have direct implications for patient care.
  4. Palliative Care Research:
    Although still important, research focusing solely on palliative care without integration into broader oncological treatment strategies has become less prominent, as the journal seeks to publish studies that combine palliative and curative approaches.
  5. Epidemiological Studies:
    The frequency of publishing epidemiological studies on cancer incidence and prevalence has decreased, possibly due to a greater focus on intervention-based research and clinical outcomes.

Similar Journals

Surgical Oncology Clinics of North America

Empowering Surgeons with Cutting-edge Knowledge
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1055-3207Frequency: 4 issues/year

Surgical Oncology Clinics of North America, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of surgical oncology and surgery, captivating readers since its inception in 1995. With ISSN 1055-3207 and E-ISSN 1558-5042, this esteemed journal offers a comprehensive platform for the dissemination of cutting-edge research, clinical studies, and expert reviews pertaining to surgical techniques and oncological advancements. The journal currently holds a commendable Q3 ranking in Oncology and a Q2 ranking in Surgery, underpinned by its impressive Scopus rankings that place it in the top 25% of its category in Medicine, particularly in the surgical domain (Rank #137/551). Although it does not operate under an open-access model, the insights shared within its pages are invaluable for researchers, healthcare professionals, and students dedicated to enhancing patient outcomes in surgical oncology. With a commitment to advancing medical knowledge, Surgical Oncology Clinics of North America remains a crucial resource for those pursuing excellence in surgical practices and oncology treatment methodologies.

CANCER INVESTIGATION

Driving innovation in cancer studies for impactful discoveries.
Publisher: TAYLOR & FRANCIS INCISSN: 0735-7907Frequency: 10 issues/year

CANCER INVESTIGATION is a distinguished peer-reviewed journal published by Taylor & Francis Inc, dedicated to the advancing field of cancer research and oncology. With an ISSN of 0735-7907 and E-ISSN of 1532-4192, this journal has been a pivotal resource for professionals and researchers since its inception in 1983, continually contributing to the evolving landscape of cancer investigation until its convergence in 2024. CANCER INVESTIGATION boasts noteworthy rankings in 2023, including Q3 in Cancer Research and Q2 in Medicine (miscellaneous), highlighting its relevance and impact in these critical areas. The journal's commitment to disseminating innovative research and comprehensive reviews makes it an essential platform for those engaged in cancer studies and related disciplines. While currently not available as an open-access publication, CANCER INVESTIGATION remains an invaluable tool for understanding the complexities of cancer, offering insights that drive scientific advancements and improve patient outcomes.

Nature Reviews Clinical Oncology

Exploring Breakthroughs in Clinical Oncology
Publisher: NATURE PORTFOLIOISSN: 1759-4774Frequency: 12 issues/year

Nature Reviews Clinical Oncology is a premier journal dedicated to the comprehensive exploration and critical evaluation of current advancements in the field of clinical oncology. Published by the esteemed NATURE PORTFOLIO in the United Kingdom, this influential journal boasts an impressive impact factor that reflects its significant role in shaping oncology research. As a Q1 ranked journal in Scopus, it occupies a notable position within the top tier of oncology publications, placing it in the 99th percentile among its peers. With a history of convergence from 2009 to 2024, it presents high-quality content through an open-access model, ensuring accessibility to vital research findings. Researchers, professionals, and students alike will find Nature Reviews Clinical Oncology an invaluable resource for staying abreast of the latest trends, biologic insights, and therapeutic innovations that drive the future of cancer treatment.

ONCOLOGY

Exploring the forefront of cancer treatment and research.
Publisher: KARGERISSN: 0030-2414Frequency: 12 issues/year

ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.

Wspolczesna Onkologia-Contemporary Oncology

Pioneering Open Access Solutions for Cancer Treatment
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1428-2526Frequency: 4 issues/year

Wspolczesna Onkologia - Contemporary Oncology is a leading open-access journal dedicated to the field of oncology and radiology, published by TERMEDIA PUBLISHING HOUSE LTD since 1999. With its ISSN 1428-2526 and E-ISSN 1897-4309, the journal has established a prominent place in scholarly publishing, contributing significantly to the advancement of cancer research and treatment modalities. Located in Poznań, Poland, it operates within a framework of high academic standards, currently holding a Q3 quartile ranking in Oncology and Q2 in Radiology, Nuclear Medicine, and Imaging for the year 2023. The journal serves as a valuable resource for researchers, medical professionals, and students alike, providing a platform for innovative studies and reviews that drive the clinical application of oncological practices. With its commitment to open access, Wspolczesna Onkologia allows for widespread dissemination of knowledge, ensuring that cutting-edge research is accessible to a global audience, thus bridging gaps in cancer care and fostering collaborative advancements in the field.

Journal of Cancer

Advancing oncology through groundbreaking research.
Publisher: IVYSPRING INT PUBLISSN: 1837-9664Frequency: 12 issues/year

Journal of Cancer is a premier, peer-reviewed academic journal published by IVYSPRING INTERNATIONAL PUBLISHING that focuses on advancing the field of oncology. With an impact factor reflecting its significant contributions, this journal ranks in the 80th percentile of medical journals pertaining to oncology, positioning it at #79 out of 404 in Scopus. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that groundbreaking research reaches a global audience without barriers. Based in Australia, the journal addresses a wide array of topics within cancer research, catering to researchers, healthcare professionals, and students committed to enhancing their understanding of the complexities of cancer. Amidst evolving challenges in oncology, the Journal of Cancer serves as a vital platform for disseminating innovative findings, fostering collaboration, and promoting informed decisions that can lead to improved cancer outcomes worldwide.

Gaceta Mexicana de Oncologia

Pioneering Insights in Cancer Studies and Care.
Publisher: SOC MEXICANA ONCOLOGIA, A CISSN: 1665-9201Frequency: 6 issues/year

Gaceta Mexicana de Oncologia, published by the SOC MEXICANA ONCOLOGIA, A C, is a prominent Open Access journal that has contributed significantly to the field of oncology since its inception in 2002. With an ISSN of 1665-9201, this journal is dedicated to disseminating high-quality research pertaining to cancer studies, making it an essential resource for researchers, healthcare professionals, and students alike. Operating out of Spain, it serves as a platform for sharing innovative findings and clinical advancements in oncology. The journal's impact in the research community is reflected in its current rankings, placing it in the Q4 category for Cancer Research and Oncology fields. Despite its emerging status within the academic tiers, Gaceta Mexicana de Oncologia aims to enhance its presence in the scholarly domain, especially during its converged years from 2009 to 2024. The accessibility of its articles empowers a wider audience, fostering collaboration and knowledge-sharing necessary for combating cancer in diverse populations.

Clinical Lung Cancer

Elevating standards in oncology and respiratory health.
Publisher: CIG MEDIA GROUP, LPISSN: 1525-7304Frequency: 6 issues/year

Clinical Lung Cancer is a prestigious journal published by CIG MEDIA GROUP, LP, dedicated to advancing the field of oncology and pulmonary medicine since its establishment in 2000. With an impressive impact factor and high ranking within its fields—achieving Q1 status in Oncology and Pulmonary and Respiratory Medicine in 2023—this journal serves as a vital resource for researchers, clinicians, and students alike. Covering a wide scope of topics related to lung cancer, Clinical Lung Cancer offers a platform for innovative studies, clinical trials, and comprehensive reviews that contribute to both theory and practice. While it operates on a subscription basis, the quality of content is reflected in its ranked status within the top quartile of cancer research journals. This journal plays a critical role in shaping the future of lung cancer research and treatment, making it an essential destination for those looking to stay at the forefront of the field.

eCancerMedicalScience

Advancing cancer research for a healthier tomorrow.
Publisher: eCancer Global FoundationISSN: 1754-6605Frequency:

eCancerMedicalScience, a leading open-access journal published by the eCancer Global Foundation, is dedicated to advancing the field of cancer research and oncology. With its inception in 2007, this esteemed journal has emerged as a pivotal platform for disseminating groundbreaking research, innovative treatments, and comprehensive reviews in the cancer domain. Based in the United Kingdom, eCancerMedicalScience has continuously contributed to the academic community with its rigorous peer-review process and broad-ranging scope, now encompassing topics from clinical oncology to molecular biology. Currently ranked in the Q3 quartile for both Cancer Research and Oncology in 2023, the journal provides a significant opportunity for researchers, professionals, and students to access valuable insights and share their findings within a global network. The commitment to open access ensures that knowledge is readily available, fostering collaborative efforts to combat cancer and improve patient outcomes.

CURRENT TREATMENT OPTIONS IN ONCOLOGY

Unveiling Tomorrow's Treatment Options Today
Publisher: SPRINGERISSN: 1527-2729Frequency: 12 issues/year

CURRENT TREATMENT OPTIONS IN ONCOLOGY, published by Springer, is a premier academic journal dedicated to disseminating cutting-edge research and advancements in the field of oncology and pharmacology. With a commendable impact factor and ranked in the Q1 category in both oncology and pharmacology for 2023, this journal positions itself as a leading resource for researchers, healthcare professionals, and students alike, offering insightful reviews and original articles that critically evaluate treatment methodologies and clinical practices. Covering a wide scope of topics from early detection to innovative therapies, it fosters the translation of research findings into clinical applications. With its convergence years spanning from 2000 to 2024, CURRENT TREATMENT OPTIONS IN ONCOLOGY continues to be at the forefront of oncological research, providing a platform for scholars to explore the latest therapeutic options and improve patient outcomes. Highly regarded in the academic community, this journal is essential for anyone looking to stay informed about the dynamic landscape of cancer treatment.